Investor Presentaiton
Creation of a global leader in out-of-hospital software (cont'd)
1
Strategic expansion of
software portfolio into Europe
Strategically aligned addition to SaaS portfolio, further supporting
ResMed's position as a leader in digital health
2
Acquisition of market leader
in Germany
3
Combination positioned to
accelerate innovation and scale
Attractive financial
4
profile
Accelerates ResMed's efforts to bring software technology along with
digital innovation to out-of-hospital care settings
Opportunity to accelerate MEDIFOX DAN's innovation together with
ResMed's deep experience in cloud and data to build complementary
offering at scale
Immediately accretive to non-GAAP EPS, with a high proportion of
recurring software revenues
42022 ResMed. Company confidential.View entire presentation